Ohio's combined medical and adult-use cannabis markets have generated $684.6 million in sales through July 11, putting the state on track to surpass its previous annual record with more than five months remaining in the year.
The state has sold 150.3 million units of marijuana products across both programs since January, according to data from the Ohio Division of Cannabis Control. The pace suggests Ohio could eclipse $1.4 billion in total sales by year-end if current trends continue.
Ohio launched adult-use sales in August 2024 after voters approved recreational marijuana in November 2023. The addition of the recreational market has significantly boosted overall cannabis sales, with the medical program—which began in 2019—now operating alongside adult-use dispensaries.
Market momentum
The $684.6 million figure represents sales from both medical patients and adult consumers. Ohio's medical cannabis program served roughly 27,000 active patients as of early 2024, while adult-use sales opened to all residents 21 and older last summer.
Industry analysts had projected Ohio's combined market could reach $1.2 billion to $1.5 billion in its first full year of adult-use sales. The state's current trajectory falls within that range, despite initial concerns about limited dispensary licenses and product availability.
Ohio dispensaries faced supply constraints in the early months of adult-use sales, with some retailers reporting periodic shortages of popular product categories. The state has since approved additional cultivation licenses to address inventory gaps.
Revenue implications
The sales figures translate to substantial tax revenue for Ohio. Adult-use cannabis carries a 10% excise tax on top of standard sales tax, while medical marijuana remains exempt from the excise levy. The state has not yet released detailed tax collection data for 2025.
Ohio's Division of Cannabis Control oversees both programs, which operate under separate regulatory frameworks despite sharing some licensed facilities. Dual-licensed dispensaries can serve both medical patients and adult-use customers, though they must maintain separate inventory tracking systems.
The 150.3 million units sold include various product forms, from flower and pre-rolls to edibles, concentrates, and topicals. Ohio regulations limit individual purchase amounts to one ounce of flower or equivalent for adult-use consumers, while medical patients can purchase larger quantities with physician recommendations.
Looking ahead
Ohio's market growth mirrors patterns seen in other states that added adult-use programs to existing medical frameworks. Illinois, which launched recreational sales in 2020, saw combined sales jump from $670 million in 2019 to $1.8 billion in 2021.
The state continues to process applications for additional retail licenses, with priority given to social equity applicants and businesses in communities disproportionately affected by cannabis prohibition. The Division of Cannabis Control has indicated it will issue more cultivation and processing licenses later this year to support market expansion.
If Ohio maintains its current sales velocity through December, the state would rank among the top 10 cannabis markets nationally by revenue, joining established programs in California, Colorado, and Michigan.
This article is based on original reporting by mjbizdaily.com.
